Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.
about
Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case reportAdoptive T cell therapy for cancer in the clinicStrategies and Advancements in Harnessing the Immune System for Gastric Cancer ImmunotherapyImmunotherapy in gastric cancerNovel immunotherapeutic strategies of gastric cancer treatmentThe Future Prospects of Immune Therapy in Gastric and Esophageal AdenocarcinomaImmunotherapy for Gastroesophageal CancerCharacterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.Gastric cancer and the epoch of immunotherapy approachesConjugation of toll-like receptor-7 agonist to gastric cancer antigen MG7-Ag exerts antitumor effects.A comparative analysis of in vitro expansion of natural killer cells of a patient with autoimmune haemolytic anaemia and ovarian cancer with patients with other solid tumours.Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.Immunotherapy for gastrointestinal malignancies.Cell Based Autologous Immune Enhancement Therapy (AIET) after Radiotherapy in a Locally Advanced Carcinoma of the Cervix.Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapyAdoptive immunotherapy: good habits instilled at youth have long-term benefits.Relapsed small cell lung cancer: treatment options and latest developments.A novel signature for stratifying the molecular heterogeneity of the tissue-infiltrating T-cell receptor repertoire reflects gastric cancer prognosis.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.Autologous immune enhancement therapy in Philadelphia chromosome positive acute lymphoblastic leukemia.Cell-based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report.Cell-based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report.Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary MalignanciesPrognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer
P2860
Q24615762-0046F931-17D3-468F-92C2-F28B20A508A3Q24680405-060AA8C9-2E16-4688-ACCD-CEB2AC03B7F1Q26823515-A06F47D2-725C-469D-8E83-BB38D78A04B7Q27010472-3016D022-1DAA-4963-91DB-7D6A57117EA8Q27011232-8297C674-3EE5-4829-8CB9-980B78940401Q28069826-FFAFC2C1-C93E-41F7-81FA-435DC14C70B7Q28069873-E8D436E9-9E55-4FFB-8161-0114A04AA315Q33236456-55133D76-14CD-46E9-917F-CAB225B1CBF6Q35550879-DAE3880D-B9F8-49C4-B856-8BDF6CEAEE2DQ35625349-2D039027-939A-43F7-8FF3-2F2033E0628CQ35843039-2EC1B686-13C5-4AF4-8E64-6CA2A30DCFA4Q35995267-F816C295-1352-4CA1-AE57-3850F731DB87Q36474559-EC790238-50DE-443F-B01E-E74142EBA2F1Q36602174-C329D255-BCB1-4067-8263-C83AF835096EQ36801493-DC3011D7-C53D-4E8A-AC99-07949C061CFBQ37053564-85D73783-73EB-498B-80D7-9C2EC26B13D5Q37107516-F749BA44-F638-43BB-BF20-7F86B4B161EFQ37257225-3BC90D52-90E6-4A48-A747-3505E85BF8F8Q37598178-0F1C96B5-5E01-420F-9699-70BCB2C75D75Q38629690-E58E6B26-8760-4B2C-937A-1A572EC195FEQ41110505-0233EC1B-FF18-482E-8875-B870C357AD13Q41869977-EA7D7D27-42FA-4A58-AA84-474D811991C7Q47137649-DD9D13AE-3834-4677-82FD-97951113DFF4Q47569250-B2B5CC95-BC0F-41F7-A02D-BF61C4A4364CQ56896166-F4DF8949-141C-4FE0-B250-F15E1695EC5CQ57167306-29D2797D-D7FE-442B-9048-16065B5A6E7B
P2860
Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prognostic significance of ado ...... ic cancer: a randomized trial.
@ast
Prognostic significance of ado ...... ic cancer: a randomized trial.
@en
Prognostic significance of ado ...... ic cancer: a randomized trial.
@nl
type
label
Prognostic significance of ado ...... ic cancer: a randomized trial.
@ast
Prognostic significance of ado ...... ic cancer: a randomized trial.
@en
Prognostic significance of ado ...... ic cancer: a randomized trial.
@nl
prefLabel
Prognostic significance of ado ...... ic cancer: a randomized trial.
@ast
Prognostic significance of ado ...... ic cancer: a randomized trial.
@en
Prognostic significance of ado ...... ic cancer: a randomized trial.
@nl
P2093
P1476
Prognostic significance of ado ...... ic cancer: a randomized trial.
@en
P2093
Akihiro Takahashi
Fumiko Ichihara
Hidehiko Iizuka
Hideki Amemiya
Hideki Fujii
Takayoshi Sekikawa
Yoshiro Matsumoto
P304
P407
P577
2002-06-01T00:00:00Z